Agenda I status definitely improves the level of complexity for almost any investigate review. One example is, all scientists—regardless of whether preclinical or clinical—must acquire Routine I research registrations. 21 CFR part 1301.18. In contrast, scientists who've DEA Practitioner registrations in Schedules II–V (which most physicians w